<HTML>
<HEAD>
<TITLE>Report of Independent Certified Public Accountants</TITLE>
</HEAD>
<BODY>

<B><P ALIGN="CENTER"></P>
<P ALIGN="CENTER">&nbsp;</P>
<p align="center"><font face="Times New Roman">UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION<br>
Washington, DC 20549</font></p>
<font size="4" face="Times New Roman">
<p align="center">FORM 8-K</p>
</font>
<p align="center"><font face="Times New Roman">CURRENT REPORT<br>
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934</font></p>
<font size="2" face="Times New Roman">
<p align="center">Date of Report (Date of earliest event reported): March 1,
2006</p>
</font><font size="5">
<p align="center"><font face="Times New Roman">BP International, Inc.<br>
</font></font><font size="2"><font face="Times New Roman">(Exact name of small
business issuer as specified in its charter)</font></p>
</font>
<p align="center">&nbsp;</p>
<center>
<table cellSpacing="0" cellPadding="0" width="638" border="0">
  <tr>
    <td vAlign="top" width="50%"><font size="2" face="Times New Roman"><b>
    <p align="center">Delaware </b></font></td>
    <td vAlign="top" width="50%"><font size="2" face="Times New Roman"><b>
    <p align="center">95-3937129</b></font></td>
  </tr>
  <tr>
    <td vAlign="top" width="50%"><font size="2" face="Times New Roman">
    <p align="center">(State or other jurisdiction of incorporation or
    organization) </font></td>
    <td vAlign="top" width="50%"><font size="2" face="Times New Roman">
    <p align="center">(I.R.S. Employer Identification No.)</font></td>
  </tr>
</table>
</center>
<p align="center">&nbsp;</p>
<center>
<table cellSpacing="0" cellPadding="0" width="638" border="0">
  <tr>
    <td vAlign="top"><font size="2" face="Times New Roman"><b>
    <p align="center">510 West Arizona Ave, DeLand, FL 32720</b></font></td>
  </tr>
  <tr>
    <td vAlign="top"><font size="2" face="Times New Roman">
    <p align="center">(Address of principal executive offices) </font></td>
  </tr>
  <tr>
    <td vAlign="top">
    <p align="left"><font face="Times New Roman">&nbsp;</font></td>
  </tr>
  <tr>
    <td vAlign="top"><font size="2" face="Times New Roman">
    <p align="center">Registrant's telephone number including area code:
    386.943.6222</font></td>
  </tr>
  <tr>
    <td vAlign="top">
    <p align="left"><font face="Times New Roman">&nbsp;</font></td>
  </tr>
  </table>
</center>
</B>
<p align="left"><b><font face="Times New Roman">Item 5.02 Departure of Directors
or Principal Officers; Election of Directors; Appointment of Principal Officers.</font></b></p>
<p align="left"><font face="Times New Roman">(a) On March 1, 2006, William
DeTemple resigned as Chief Financial Officer of the Registrant. Mr. DeTemple
retains his position as President, CEO, and board member of the Registrant.<br>
<br>
(b) On March 1, 2006, concurrently with Mr. DeTemple's resignation, Tami L.
Tharp was appointed to the position of Chief Financial Officer of the
Registrant. Ms. Tharp joined the Registrant in an accounting support capacity in
February of 2006. From May, 2005 until February, 2006, Ms. Tharp served as an
independent consultant providing accounting services. From May, 2002 to May,
2005, she served as Chief Financial Officer of RMS Limited Partnerships, LLC.
From January, 2001 to March, 2002, she served as Corporate Controller of
CuraScripts Pharmacy, Inc.</font></p>
<B>
<p align="center"><font face="Times New Roman">SIGNATURES</font></p>
</B>
<p align="left"><font face="Times New Roman">Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.<br>
<B>
<br>
BP International, Inc.<br>
March 16, 2006<br>
<br>
<i>/s/ Tami Tharp</i><br>
___________________________________________<br>
Tami Tharp,<br>
CFO of BP International, Inc.<br>
<br>
&nbsp;</B></font><B></p>
</B>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "bpil_8k-060301.htm", "secsgml_size_bytes": 3942}]
{"company-data": {"conformed-name": "BP INTERNATIONAL INC", "cik": "0001082737", "assigned-sic": "3949", "irs-number": "953937129", "state-of-incorporation": "DE", "fiscal-year-end": "0531"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-26189", "film-number": "06691789"}, "business-address": {"street1": "510 W ARIZONA AVENUE", "city": "DELAND", "state": "FL", "zip": "32720", "phone": "3869436222"}, "mail-address": {"street1": "510 W ARIZONA AVE", "city": "DELAND", "state": "FL", "zip": "32720"}, "former-company": {"former-conformed-name": "ALLERGY IMMUNO TECHNOLOGIES INC", "date-changed": "19990325"}}
Report of Independent Certified Public Accountants
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 1,
2006
BP International, Inc.
(Exact name of small
business issuer as specified in its charter)
Delaware
95-3937129
(State or other jurisdiction of incorporation or
    organization)
(I.R.S. Employer Identification No.)
510 West Arizona Ave, DeLand, FL 32720
(Address of principal executive offices)
Registrant's telephone number including area code:
    386.943.6222
Item 5.02 Departure of Directors
or Principal Officers; Election of Directors; Appointment of Principal Officers.
(a) On March 1, 2006, William
DeTemple resigned as Chief Financial Officer of the Registrant. Mr. DeTemple
retains his position as President, CEO, and board member of the Registrant.
(b) On March 1, 2006, concurrently with Mr. DeTemple's resignation, Tami L.
Tharp was appointed to the position of Chief Financial Officer of the
Registrant. Ms. Tharp joined the Registrant in an accounting support capacity in
February of 2006. From May, 2005 until February, 2006, Ms. Tharp served as an
independent consultant providing accounting services. From May, 2002 to May,
2005, she served as Chief Financial Officer of RMS Limited Partnerships, LLC.
From January, 2001 to March, 2002, she served as Corporate Controller of
CuraScripts Pharmacy, Inc.
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
BP International, Inc.
March 16, 2006
/s/ Tami Tharp
___________________________________________
Tami Tharp,
CFO of BP International, Inc.